In breast cancer, LYN has been reported as overexpressed and a potential drug target in TNBC by several studies (Choi et al., 2010, Hochgräfe et al., 2010, Molyneux et al., 2010, Regan et al., 2012, Smart et al., 2011). This evidence concerns the gene LYN and breast cancer.